The clinical application of PIVKA‐II in hepatocellular carcinoma and chronic liver diseases: A multi‐center study in China

BACKGROUND: Due to the absence of specific symptoms and low survival rate, efficient biomarkers for hepatocellular carcinoma (HCC) diagnosis are urgently required. The purpose of this study was to evaluate the diagnostic performance of protein induced by vitamin K absence or antagonist‐II (PIVKA‐II)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Jun, Liu, Lijuan, Jiang, Feifei, Wen, Xue, Zhang, Yu, Li, Shengcong, Lou, Jinli, Wang, Ying, Liu, Ning, Guo, Qiuyan, Jia, Yongmei, Gao, Chunfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605129/
https://www.ncbi.nlm.nih.gov/pubmed/34590755
http://dx.doi.org/10.1002/jcla.24013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605129/
https://www.ncbi.nlm.nih.gov/pubmed/34590755
http://dx.doi.org/10.1002/jcla.24013

Ejemplares similares